Immediate lymphatic reconstruction for the prevention of breast cancer-related lymphedema: an experience highlighting the importance of lymphatic anatomy

Abstract

Immediate lymphatic reconstruction (ILR) has become increasingly utilized for the prevention of breast cancer-related lymphedema (BCRL). A growing body of evidence has demonstrated the long-term efficacy of ILR in reducing the rate of BCRL. While certain risk factors for BCRL are well-recognized, such as axillary lymph node dissection, regional lymph node radiation, and elevated body mass index, other potential risk factors such as age and taxane-based chemotherapeutics remain under discussion. Our experience with ILR has highlighted an additional potential risk factor for BCRL. Lymphatic anatomy, specifically compensatory lymphatic channels that bypass the axilla, may play a largely underrecognized role in determining which patients will develop BCRL after ILR. Foundational anatomic knowledge has primarily been based on cadaveric studies that predate the twentieth century. Modern approaches to lymphatic anatomical mapping using indocyanine green lymphography have helped to elucidate baseline lymphatic anatomy and compensatory channels, and certain variations within these channels may act as anatomic risk factors. Therefore, the purpose of this review was to highlight ways in which variations in lymphatic anatomy can inform the application and improve the accessibility of this procedure. As ILR continues to advance and evolve, anatomical mapping of the lymphatic system is valuable to both the patient and lymphatic microsurgeon and is a critical area of future study.

Keywords

Lymphatic anatomy / immediate lymphatic reconstruction / lymphedema

References

[1] Gillespie TC,Brunelle CL,Taghian AG.Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.Gland Surg2018;7:379-403 PMCID:PMC6107585

[2] Armer JM,Porock D.Predicting breast cancer-related lymphedema using self-reported symptoms.Nurs Res2003;52:370-9

[3] Fu MR.Breast cancer survivors' experiences of lymphedema-related symptoms.J Pain Symptom Manage2009;38:849-59 PMCID:PMC2795115

[4] Jørgensen MG,Madsen AR.Cellulitis is associated with severe breast cancer-related lymphedema: an observational study of tissue composition.Cancers2021;13:3584 PMCID:PMC8303539

[5] Jørgensen MG,Hansen FG,Sørensen JA.The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment.NPJ Breast Cancer2021;7:70 PMCID:PMC8169644

[6] Khan F,Pallant JF.Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer.Breast2012;21:314-20

[7] Boyages J,Kalfa S.Financial cost of lymphedema borne by women with breast cancer.Psychooncology2017;26:849-55 PMCID:PMC5484300

[8] Johnson AR,Granoff MD.Is Immediate lymphatic reconstruction cost-effective?.Ann Surg2021;274:e581-8

[9] Shaitelman SF,Rasmussen JC.Recent progress in the treatment and prevention of cancer-related lymphedema.CA Cancer J Clin2015;65:55-81 PMCID:PMC4808814

[10] Martínez-Jaimez P,Forero CG.Breast cancer-related lymphoedema: risk factors and prediction model.J Adv Nurs2022;78:765-75

[11] Johnson AR,Epstein S.Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach.Ann Plast Surg2019;82:S234-41

[12] DiSipio T,Newman B.Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.Lancet Oncol2013;14:500-15

[13] Hill WKF,Platt A,Jost E.Immediate lymphatic reconstruction during axillary node dissection for breast cancer: a systematic review and meta-analysis.Plast Reconstr Surg Glob Open2022;10:e4291 PMCID:PMC9084431

[14] Pereira ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.Breast2017;36:67-73

[15] Montagna G,Sevilimedu V.Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema.JAMA Oncol2022;8:1195-200

[16] Ahmad A.Breast Cancer Statistics: Recent Trends. In: Ahmad A, editor. Breast cancer metastasis and drug resistance. Cham: Springer International Publishing; 2019. pp. 1-7.

[17] Schulze H,Gutenbrunner C.Worldwide assessment of healthcare personnel dealing with lymphoedema.Health Econ Rev2018;8:10 PMCID:PMC5901432

[18] Duhon BH,Taylor SL,Rutkowski JM.Current mechanistic understandings of lymphedema and lipedema: tales of fluid, fat, and fibrosis.Int J Mol Sci2022;23:6621 PMCID:PMC9223758

[19] Avraham T,Yan A.Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.FASEB J2013;27:1114-26 PMCID:PMC3574290

[20] Savetsky IL,Gardenier JC.Th2 cytokines inhibit lymphangiogenesis.PLoS One2015;10:e0126908 PMCID:PMC4454507

[21] Ogata F,Matsumoto S.Excess lymphangiogenesis cooperatively induced by macrophages and CD4(+) T cells drives the pathogenesis of lymphedema.J Invest Dermatol2016;136:706-14

[22] Baik JE,Kataru RP.TGF-β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation.Clin Transl Med2022;12:e758

[23] Hespe G,Mehrara B. Pathophysiology of lymphedema. Available from:

[24] Aschen S,Elhadad S,De Brot Andrade M.Regulation of adipogenesis by lymphatic fluid stasis: part II. expression of adipose differentiation genes.Plast Reconstr Surg2012;129:838-47 PMCID:PMC3445411

[25] Miaskowski C,Paul SM.Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.PLoS One2013;8:e60164 PMCID:PMC3629060

[26] Finegold DN,Knickelbein KZ.Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.Clin Cancer Res2012;18:2382-90 PMCID:PMC3625665

[27] Finegold DN,Kimak MA.HGF and MET mutations in primary and secondary lymphedema.Lymphat Res Biol2008;6:65-8 PMCID:PMC4298750

[28] Rockson SG,Kilbreath S,Towers A.Cancer-associated secondary lymphoedema.Nat Rev Dis Primers2019;5:22

[29] Sudduth CL.Primary lymphedema: update on genetic basis and management.Adv Wound Care2022;11:374-81 PMCID:PMC9051871

[30] Ahmed RL,Prizment AE.Risk factors for lymphedema in breast cancer survivors, the iowa women's health study.Breast Cancer Res Treat2011;130:981-91 PMCID:PMC4091732

[31] Tsai RJ,Lynch CF,Zamba GK.The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.Ann Surg Oncol2009;16:1959-72

[32] Yusof KM,Ahmad Suhaimi S.Assessment of potential risk factors and skin ultrasound presentation associated with breast cancer-related lymphedema in long-term breast cancer survivors.Diagnostics2021;11:1303 PMCID:PMC8393908

[33] Armer JM,McCall L.Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection.JAMA Surg2019;154:800-9 PMCID:PMC6647005

[34] Ariel IM,Oropeza R.The effects of irradiation (external and internal) on lymphatic dynamics.Am J Roentgenol Radium Ther Nucl Med1967;99:404-14

[35] LENZI M.The effect of radiation on the lymph and on the lymph vessels.Radiology1963;80:814-7

[36] Allam O,Chandler L.The impact of radiation on lymphedema: a review of the literature.Gland Surg2020;9:596-602 PMCID:PMC7225495

[37] Warren LE,Horick N.The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.Int J Radiat Oncol Biol Phys2014;88:565-71 PMCID:PMC3928974

[38] Manirakiza A,Shui L,Ngendahayo L.Lymphoedema after breast cancer treatment is associated with higher body mass index: a systematic review and meta-analysis.East Afr Health Res J2019;3:178-92 PMCID:PMC8279288

[39] Wu R,Dong X,Zhuang L.Obese patients have higher risk of breast cancer-related lymphedema than overweight patients after breast cancer: a meta-analysis.Ann Transl Med2019;7:172 PMCID:PMC6526274

[40] Ridner SH,Stewart BR.Body mass index and breast cancer treatment-related lymphedema.Support Care Cancer2011;19:853-7 PMCID:PMC4480912

[41] Mehrara BJ.Lymphedema and obesity: is there a link?.Plast Reconstr Surg2014;134:154e-60e PMCID:PMC4393748

[42] Zhu W,Li X.Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema.Anticancer Drugs2017;28:350-5

[43] Hugenholtz-Wamsteker W,Nijs J,Meeus M.The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review.Eur J Cancer Care2016;25:269-79

[44] Kim M,Lee SU.A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.Int J Radiat Oncol Biol Phys2013;86:498-503

[45] Cariati M,Grootendorst MR.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Br J Surg2015;102:1071-8

[46] Kilbreath SL,Beith JM.Risk factors for lymphoedema in women with breast cancer: a large prospective cohort.Breast2016;28:29-36

[47] Swaroop MN,Horick NK.Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.Breast Cancer Res Treat2015;151:393-403 PMCID:PMC4432026

[48] Johnson AR,Lee BT,Bouta EM.The impact of taxane-based chemotherapy on the lymphatic system.Ann Plast Surg2019;82:S173-8

[49] Specht MC,Skolny MN.Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.Ann Surg Oncol2013;20:2835-41

[50] Jung SY,Kim M.Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.Breast Cancer Res Treat2014;148:91-8

[51] Wilke LG,Posther KE.Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.Ann Surg Oncol2006;13:491-500

[52] Kim M,Lee KS.Breast cancer-related lymphedema after neoadjuvant chemotherapy.Cancer Res Treat2015;47:416-23

[53] Hayes SC,Cornish B,Newman B.Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.J Clin Oncol2008;26:3536-42

[54] Shang T,Kapron CM.Pathophysiology of aged lymphatic vessels.Aging2019;11:6602-13 PMCID:PMC6738433

[55] Kwan ML,Lee VS.Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the pathways study.Breast Cancer Res Treat2016;159:119-29 PMCID:PMC5010992

[56] Meeske KA,Smith AW.Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women.Breast Cancer Res Treat2009;113:383-91

[57] Guliyeva G,Boczar D,Lu X.Age as a risk factor for breast cancer-related lymphedema: a systematic review.J Cancer Surviv2023;17:246-53

[58] Zou L,Shen PP.The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.Breast Cancer2018;25:309-14

[59] Byun HK,Chang JS.Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: a large multi-institutional study (KROG 20-05).Breast Cancer Res Treat2022;192:553-61

[60] Siotos C,Bello RJ.Delayed breast reconstruction on patients with upper extremity lymphedema: a systematic review of the literature and pooled analysis.Ann Plast Surg2018;81:730-5

[61] Basta MN,Kanchwala SK.A propensity-matched analysis of the influence of breast reconstruction on subsequent development of lymphedema.Plast Reconstr Surg2015;136:134e-43e

[62] McLaughlin SA,Taghian A.Breast Cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment.J Clin Oncol2020;38:2341-50 PMCID:PMC7343436

[63] Yamada Y. The studies on lymphatic venous anastomosis in lvmphedema. Available from: https://scholar.google.com/scholar?hl=zh-CN&as_sdt=0%2C5&q=Yamada+Y.+The+Studies+on+Lymphatic+Venous+Anastomosis+in+Lvmphedema.+Nagoya+J+Med+Sci.+1969%3B32%3A1-21.&btnG [Last accessed on 22 May 2023]

[64] Boccardo F,De Cian F.Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy.Ann Surg Oncol2009;16:703-8

[65] Boccardo F,De Cian F.Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up.Microsurgery2014;34:421-4

[66] Johnson AR.Immediate lymphatic reconstruction.J Surg Oncol2018;118:750-7

[67] Coriddi M,Skoracki R,Dayan JH.Immediate lymphatic reconstruction: technical points and literature review.Plast Reconstr Surg Glob Open2021;9:e3431 PMCID:PMC7929616

[68] Wiser I,Kenworthy E,Dayan J.Standardizing upper extremity indocyanine green lymphography in a lymphedema outpatient setting.Plast Reconstr Surg Glob Open2020;8:45.

[69] Spiguel L,Katz A.Fluorescein isothiocyanate: a novel application for lymphatic surgery.Ann Plast Surg2017;78:S296-8

[70] Russell PS,Maldonado Zimbrón VE.Fluorescent tracers for in vivo imaging of lymphatic targets.Front Pharmacol2022;13:952581 PMCID:PMC9355481

[71] Abdallah M,Styles IK.Lymphatic targeting by albumin-hitchhiking: Applications and optimisation.J Control Release2020;327:117-28

[72] Trevaskis NL,Porter CJ.From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.Nat Rev Drug Discov2015;14:781-803

[73] Mele A,Pardo J.Axillary lymph node dissection in the era of immediate lymphatic reconstruction: Considerations for the breast surgeon.J Surg Oncol2021;123:842-5

[74] Visconti G,Hayashi N.Ultrasound-assisted lymphaticovenular anastomosis for the treatment of peripheral lymphedema.Plast Reconstr Surg2017;139:1380e-1e

[75] Caretto AA,Garganese G.Treatment of early-stage gynecological cancer-related lower limb lymphedema by lymphaticovenular anastomosis-the triple incision approach.Medicina2022;58:631

[76] Schwarz GS,Djohan RS.Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow.J Surg Oncol2019;120:160-7

[77] Gagne P.Relationship of common vascular anatomy to cannulated catheters.Int J Vasc Med2017;2017:5157914 PMCID:PMC5749287

[78] Nomoto S,Ogawa R.Safety of copolyamide filler injection for breast augmentation.Plast Reconstr Surg Glob Open2021;9:e3296 PMCID:PMC7929552

[79] Yamamoto T,Yamashita M,Hayashi A.Efferent lymphatic vessel anastomosis: supermicrosurgical efferent lymphatic vessel-to-venous anastomosis for the prophylactic treatment of subclinical lymphedema.Ann Plast Surg2016;76:424-7

[80] Gentileschi S,Pino V.SPECT/CT and fusion ultrasound to target the efferent groin lymph node for lymphatic surgery.Microsurgery2019;39:605-12

[81] Gentileschi S,Garganese G.The lymphatic superficial circumflex iliac vessels deep branch perforator flap: a new preventive approach to lower limb lymphedema after groin dissection-preliminary evidence.Microsurgery2017;37:564-73

[82] Caretto AA,Fragomeni SM.Lymphatic function of the lower limb after groin dissection for vulvar cancer and reconstruction with lymphatic SCIP flap.Cancers2022;14:1076 PMCID:PMC8870617

[83] Samra F,Nelson JA,Mehrara B.Frontiers in oncologic reconstruction.Plast Reconstr Surg Glob Open2019;7:e2181 PMCID:PMC6635183

[84] Chen WF.Delayed distally based prophylactic lymphaticovenular anastomosis: improved functionality, feasibility, and oncologic safety?.J Reconstr Microsurg2020;36:e1-2

[85] Johnson AR,Bates K.Creating a policy for coverage of lymphatic surgery: addressing a critical unmet need.Plast Reconstr Surg2023;10.1097/prs.0000000000010239:

[86] Johnson AR,Tran BNN.Developing a lymphatic surgery program: a first-year review.Plast Reconstr Surg2019;144:975e-85e

[87] Bracaglia R,Gentileschi S.Was the surgeon a satisfactory informant?.Aesthet Surg J2014;34:632-5

[88] Sappey M,Beau E. Anatomie, Physiologie, Pathologie de Vaisseaux Lymphatiques. Adrain Delahaye, Imprimerie de E. Martinet; 1874. Available from: https://archive.org/details/BIUSante_01562/page/n1/mode/2up [Last accessed on 22 May 2023]

[89] Suami H.Lymphosome concept: Anatomical study of the lymphatic system.J Surg Oncol2017;115:13-7

[90] Suami H.Anatomy of the lymphatic system and the lymphosome concept with reference to lymphedema.Semin Plast Surg2018;32:5-11 PMCID:PMC5891651

[91] Tourani SS,Ashton MW.Anatomy of the superficial lymphatics of the abdominal wall and the upper thigh and its implications in lymphatic microsurgery.J Plast Reconstr Aesthet Surg2013;66:1390-5

[92] Johnson AR,James TA,Lee BT.The all but forgotten mascagni-sappey pathway: learning from immediate lymphatic reconstruction.J Reconstr Microsurg2020;36:28-31

[93] Kubik S.The role of the lateral upper arm bundle and the lymphatic watersheds in the formation of collateral pathways in lymphedema.Acta bio Acad Sci Hung1980;31:191-200

[94] Johnson AR,Suami H,Singhal D.Real-time visualization of the mascagni-sappey pathway utilizing ICG lymphography.Cancers2020;12:1195 PMCID:PMC7281680

[95] Ciucci J. Derivative lymphatic currents UL, Ciucci, JL - English. In: Linfedema Del Miembro Superior Postratamiento Del Cancer de Mama. Nayarit Ed; 2004:29. Available from: https://linfedemahoy.com/linfedema-de-miembro-superior [Last accessed on 22 May 2023]

[96] Latorre J,Rosendo A. Anatomía Del Sistema Linfático Del Miembro Superior Revisión. Available from: https://filadd.com [Last accessed on 22 May 2023]

[97] Ciucci JL,Sorocco J. Investigación anatómica del drenaje linfático del miembro superior. Su importancia en la patología traumatológica. Available from: https://www.aaot.org.ar/revista/1993_2002/1997/1997_4/620413.pdf [Last accessed on 22 May 2023]

[98] Amore M,Mercado D,Ciucci J.Lymphedema: a general outline of its anatomical base.J Reconstr Microsurg2016;32:2-9

[99] Friedman R,Pardo J.Superficial and functional imaging of the tricipital lymphatic pathway: a modern reintroduction.Breast Cancer Res Treat2023;197:235-42

[100] Granoff MD,Johnson AR.Superficial and functional lymphatic anatomy of the upper extremity.Plast Reconstr Surg2022;150:900-7 PMCID:PMC9674086

[101] Granoff MD,Shillue K.Variable anatomy of the lateral upper arm lymphatic channel: a potential anatomic risk factor for the development of breast cancer related lymphedema.Plast Reconstr Surg2023;

[102] Paramanandam VS,Clark GM.Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial.J Clin Oncol2022;40:2004-12

[103] Koelmeyer LA,Mackie H.Personalizing conservative lymphedema management using indocyanine green-guided manual lymphatic drainage.Lymphat Res Biol2021;19:56-65

[104] Gross JP,Helenowski IB.Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer.Int J Radiat Oncol Biol Phys2018;102:71-8

[105] Brown S,Coriddi M.Pharmacological treatment of secondary lymphedema.Front Pharmacol2022;13:828513 PMCID:PMC8822213

[106] Shah C.Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.Int J Radiat Oncol Biol Phys2011;81:907-14